Clinical trials
Suspended Lung Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UNC Lineberger Comprehensive Cancer Center | 2 |
| City of Hope Medical Center | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Dwight Owen | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
| Roger Williams Medical Center | 1 |
| Stanford University | 1 |
| University of California, Davis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 13 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Neoplasms | 4 |
| Breast Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Alzheimer Disease | 1 |
| Anxiety Disorders | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.